Utilizing focused ultrasound, the Sonablate system is a minimally invasive robotic device that delivers precise and focused ablative energy. This new surgical option for prostate cancer gives surgeons minimally invasive options for destroying unhealthy tissue with thermal ablation throughout the body. This is a new treatment paradigm that combines elements from radiology, needle ablation and surgery to effectively ablate targeted tissue with minimal impact on a patient’s quality of life.
- Reduced side effect profiles
- Reduced procedure time
- Tissue sparing intervention across specialties
- More favorable outcomes via “non-cutting” intervention.
- Imaging and feedback tools provide live results from targeted area(s)
- Increases the number of patients appropriate for surgical intervention
- Reduces costs associated with surgical intervention
- Minimally Invasive
- Real-time Imaging
- Radiation Free
Don’t wait until it’s too late.
The Sonablate® obtains real-time ultrasound images of the prostate and surrounding areas. From these images, the doctor plans where the ultrasound energy will be delivered. The Sonablate® software allows the surgeon to visually direct the treatment and precisely define the treatment zones in order to destroy the entire gland or selected portions (focal therapy).
Unlike radiation, HIFU is non-ionizing so it can be repeated, if necessary, without damaging healthy tissue. This means that HIFU can also be used as a salvage technique if other prostate cancer treatments fail.
The Sonablate® is the only non-invasive HIFU device for prostate cancer that does not require a transurethral resection of the prostate (TURP), an invasive surgical procedure for moderate and large prostates, prior to treatment in order to achieve effective results. The Sonablate® is also the only visually directed HIFU device.
Who is a Candidate for HIFU with the Sonablate®?
Sonablate® HIFU is most effective for men who have early stage, localized prostate cancer that has not spread or metastasized outside the prostate. However, it is recommended that you discuss your individual medical records and history with a physician in order to confirm whether or not you are a candidate for HIFU.
HIFU for Recurrent Prostate Cancer
Many patients who have had radiation therapy, brachytherapy or external beam radiation and experience a rise in PSA have discovered that the cancer is back. These patients may be candidates for HIFU as well, as long as the cancer has not spread to the bone or other organs.
Additionally, patients who have a local recurrence after receiving a radical prostatectomy may qualify for HIFU.
Dr. Michael Lazar, a Santa Rosa urologist and prostate cancer expert, is the only Northern California physician recognized as a leader in the use of high-intensity focused ultrasound (HIFU) for prostate cancer. He has been successfully treating patients with HIFU since 2007.
“I invite you to contact me at my office in Northern California to begin discussing your prostate cancer treatment options.”
Call (707) 546-5553 for more information, or fill out our qualification form.